Bellus Health

-$0.07 (-2.50%) As of 3:34 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Bellus Health and other ETFs, options, and stocks.

About BLU

BELLUS Health, Inc. is a biopharmaceutical development company which engages in the research and development of novel therapeutics for the treatment of chronic cough and other hypersensitisation disorders. Its product, BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch.

CEO
Roberto Bellini
Employees
—
Headquarters
Laval, Québec
Founded
1993

BLU Key Statistics

Market Cap
264.75M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
341.74K
High Today
$2.83
Low Today
$2.71
Open Price
$2.82
Volume
79.19K
52 Week High
$4.96
52 Week Low
$2.01

BLU Earnings

-$0.20
-$0.13
-$0.07
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 12, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure